Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims

Background: The religious seasons of Hajj and Umra in the Kingdom of Saudi Arabia (KSA) have historically been associated with epidemics of meningococcal disease. Due to the effective preventive measures taken in recent years, including vaccination, no meningococcal outbreaks have been reported duri...

Full description

Bibliographic Details
Main Authors: Ziad A. Memish, Saber Yezli, Malak Almasri, Abdullah Assiri, Abdulhafeez Turkestani, Helen Findlow, Xilian Bai, Ray Borrow
Format: Article
Language:English
Published: Elsevier 2014-11-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971214016294
_version_ 1811283668333756416
author Ziad A. Memish
Saber Yezli
Malak Almasri
Abdullah Assiri
Abdulhafeez Turkestani
Helen Findlow
Xilian Bai
Ray Borrow
author_facet Ziad A. Memish
Saber Yezli
Malak Almasri
Abdullah Assiri
Abdulhafeez Turkestani
Helen Findlow
Xilian Bai
Ray Borrow
author_sort Ziad A. Memish
collection DOAJ
description Background: The religious seasons of Hajj and Umra in the Kingdom of Saudi Arabia (KSA) have historically been associated with epidemics of meningococcal disease. Due to the effective preventive measures taken in recent years, including vaccination, no meningococcal outbreaks have been reported during Hajj or were Hajj-associated. However, little is known about the immunological profile of pilgrims. The aim of this study was to assess the immunological profile of pilgrims on arrival in KSA against the four meningococcal serogroups, A, C, W, and Y, contained within the quadrivalent vaccine. Methods: Following consent, socio-demographic factors and health-related information was collected from pilgrims arriving at King Abdul Aziz International Airport and a blood sample taken. Antibodies were quantified by serum bactericidal antibody assay using baby rabbit complement (rSBA) against the four meningococcal serogroups, A, C, W, and Y. Results: Serum samples were collected from 796 pilgrims; rSBA results were obtained for all four serogroups for 741 of these samples. A total of 48 (6.5%) Hajjis had previously attended Hajj, ranging from 1 to 14 times (median 2 times); 98.2% had received meningococcal quadrivalent vaccine in the last 3 years. Of the 13 who had not, all originated from Bangladesh, with four reporting no previous meningococcal vaccination and nine reporting having received the vaccination more than 3 years ago. For serogroup A, only one pilgrim from Indonesia had an rSBA titre <8. For serogroups C, W, and Y, the percentages of pilgrims with rSBA titres <8 were 9.9%, 17.4%, and 9.4%, respectively. Of note was the high prevalence of non-complement-mediated lysis in pilgrims originating from Nigeria (28/47; 59.6%) and Afghanistan (21/47; 44.7%), but not the other countries. This may be a reflection of the type and pattern of antibiotic usage among these communities. Conclusion: The vast majority of pilgrims are vaccinated and protected against meningococcal serogroups A, C, W, and Y.
first_indexed 2024-04-13T02:15:43Z
format Article
id doaj.art-3f77c9800b1f4d1b95cd683c0201fa58
institution Directory Open Access Journal
issn 1201-9712
1878-3511
language English
last_indexed 2024-04-13T02:15:43Z
publishDate 2014-11-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj.art-3f77c9800b1f4d1b95cd683c0201fa582022-12-22T03:07:09ZengElsevierInternational Journal of Infectious Diseases1201-97121878-35112014-11-0128C17117510.1016/j.ijid.2014.09.005Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrimsZiad A. Memish0Saber Yezli1Malak Almasri2Abdullah Assiri3Abdulhafeez Turkestani4Helen Findlow5Xilian Bai6Ray Borrow7Global Centre for Mass Gatherings Medicine (GCMGM), Ministry of Health, Riyadh, Kingdom of Saudi ArabiaGlobal Centre for Mass Gatherings Medicine (GCMGM), Ministry of Health, Riyadh, Kingdom of Saudi ArabiaGlobal Centre for Mass Gatherings Medicine (GCMGM), Ministry of Health, Riyadh, Kingdom of Saudi ArabiaGlobal Centre for Mass Gatherings Medicine (GCMGM), Ministry of Health, Riyadh, Kingdom of Saudi ArabiaMakkah Regional Health Affairs, Ministry of Health, Makkah, Kingdom of Saudi ArabiaVaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, UKVaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, UKVaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, UKBackground: The religious seasons of Hajj and Umra in the Kingdom of Saudi Arabia (KSA) have historically been associated with epidemics of meningococcal disease. Due to the effective preventive measures taken in recent years, including vaccination, no meningococcal outbreaks have been reported during Hajj or were Hajj-associated. However, little is known about the immunological profile of pilgrims. The aim of this study was to assess the immunological profile of pilgrims on arrival in KSA against the four meningococcal serogroups, A, C, W, and Y, contained within the quadrivalent vaccine. Methods: Following consent, socio-demographic factors and health-related information was collected from pilgrims arriving at King Abdul Aziz International Airport and a blood sample taken. Antibodies were quantified by serum bactericidal antibody assay using baby rabbit complement (rSBA) against the four meningococcal serogroups, A, C, W, and Y. Results: Serum samples were collected from 796 pilgrims; rSBA results were obtained for all four serogroups for 741 of these samples. A total of 48 (6.5%) Hajjis had previously attended Hajj, ranging from 1 to 14 times (median 2 times); 98.2% had received meningococcal quadrivalent vaccine in the last 3 years. Of the 13 who had not, all originated from Bangladesh, with four reporting no previous meningococcal vaccination and nine reporting having received the vaccination more than 3 years ago. For serogroup A, only one pilgrim from Indonesia had an rSBA titre <8. For serogroups C, W, and Y, the percentages of pilgrims with rSBA titres <8 were 9.9%, 17.4%, and 9.4%, respectively. Of note was the high prevalence of non-complement-mediated lysis in pilgrims originating from Nigeria (28/47; 59.6%) and Afghanistan (21/47; 44.7%), but not the other countries. This may be a reflection of the type and pattern of antibiotic usage among these communities. Conclusion: The vast majority of pilgrims are vaccinated and protected against meningococcal serogroups A, C, W, and Y.http://www.sciencedirect.com/science/article/pii/S1201971214016294MeningococcalPilgrimageHajjVaccineSerum bactericidal antibody
spellingShingle Ziad A. Memish
Saber Yezli
Malak Almasri
Abdullah Assiri
Abdulhafeez Turkestani
Helen Findlow
Xilian Bai
Ray Borrow
Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims
International Journal of Infectious Diseases
Meningococcal
Pilgrimage
Hajj
Vaccine
Serum bactericidal antibody
title Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims
title_full Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims
title_fullStr Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims
title_full_unstemmed Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims
title_short Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims
title_sort meningococcal serogroup a c w and y serum bactericidal antibody profiles in hajj pilgrims
topic Meningococcal
Pilgrimage
Hajj
Vaccine
Serum bactericidal antibody
url http://www.sciencedirect.com/science/article/pii/S1201971214016294
work_keys_str_mv AT ziadamemish meningococcalserogroupacwandyserumbactericidalantibodyprofilesinhajjpilgrims
AT saberyezli meningococcalserogroupacwandyserumbactericidalantibodyprofilesinhajjpilgrims
AT malakalmasri meningococcalserogroupacwandyserumbactericidalantibodyprofilesinhajjpilgrims
AT abdullahassiri meningococcalserogroupacwandyserumbactericidalantibodyprofilesinhajjpilgrims
AT abdulhafeezturkestani meningococcalserogroupacwandyserumbactericidalantibodyprofilesinhajjpilgrims
AT helenfindlow meningococcalserogroupacwandyserumbactericidalantibodyprofilesinhajjpilgrims
AT xilianbai meningococcalserogroupacwandyserumbactericidalantibodyprofilesinhajjpilgrims
AT rayborrow meningococcalserogroupacwandyserumbactericidalantibodyprofilesinhajjpilgrims